Ralfinamide mesylate (FCE-26742A mesylate) is an orally available Na+ channel blocker derived from α-aminoamide, with function of suppressing pain.

Product information

CAS Number: 202825-45-4

Molecular Weight: 398.45

Formula: C18H23FN2O5S

Chemical Name: (2S)-2-[({4-[(2-fluorophenyl)methoxy]phenyl}methyl)amino]propanamide; methanesulfonic acid

Smiles: C[C@H](NCC1C=CC(=CC=1)OCC1=CC=CC=C1F)C(N)=O.CS(O)(=O)=O

InChiKey: CHQVNINIGBRKGZ-YDALLXLXSA-N

InChi: InChI=1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vivo:

Ralfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain.

Products are for research use only. Not for human use.